栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/11 | 1,385 | 1,389 | 1,373 | 1,380 | ±0 | ±0% | 121,600 |
2023/09/08 | 1,390 | 1,398 | 1,375 | 1,380 | -21 | -1.5% | 250,600 |
2023/09/07 | 1,406 | 1,409 | 1,397 | 1,401 | -8 | -0.6% | 139,900 |
2023/09/06 | 1,410 | 1,412 | 1,403 | 1,409 | +1 | +0.1% | 83,500 |
2023/09/05 | 1,408 | 1,413 | 1,400 | 1,408 | -6 | -0.4% | 136,500 |
2023/09/04 | 1,405 | 1,418 | 1,401 | 1,414 | +9 | +0.6% | 131,600 |
2023/09/01 | 1,400 | 1,408 | 1,395 | 1,405 | +5 | +0.4% | 173,400 |
2023/08/31 | 1,400 | 1,404 | 1,392 | 1,400 | -1 | -0.1% | 159,500 |
2023/08/30 | 1,408 | 1,410 | 1,398 | 1,401 | -3 | -0.2% | 108,900 |
2023/08/29 | 1,400 | 1,407 | 1,394 | 1,404 | +6 | +0.4% | 82,100 |
2023/08/28 | 1,400 | 1,404 | 1,392 | 1,398 | +8 | +0.6% | 123,600 |
2023/08/25 | 1,379 | 1,393 | 1,370 | 1,390 | +3 | +0.2% | 111,700 |
2023/08/24 | 1,393 | 1,395 | 1,382 | 1,387 | -15 | -1.1% | 118,000 |
2023/08/23 | 1,379 | 1,402 | 1,370 | 1,402 | +7 | +0.5% | 194,300 |
2023/08/22 | 1,399 | 1,399 | 1,383 | 1,395 | -9 | -0.6% | 121,600 |
2023/08/21 | 1,382 | 1,407 | 1,377 | 1,404 | +19 | +1.4% | 165,800 |
2023/08/18 | 1,386 | 1,391 | 1,376 | 1,385 | -14 | -1% | 144,100 |
2023/08/17 | 1,414 | 1,414 | 1,383 | 1,399 | -30 | -2.1% | 211,800 |
2023/08/16 | 1,433 | 1,437 | 1,419 | 1,429 | -10 | -0.7% | 131,400 |
2023/08/15 | 1,438 | 1,445 | 1,430 | 1,439 | +1 | +0.1% | 109,900 |
2023/08/14 | 1,452 | 1,458 | 1,434 | 1,438 | -8 | -0.6% | 100,700 |
2023/08/10 | 1,442 | 1,446 | 1,425 | 1,446 | -1 | -0.1% | 140,700 |
2023/08/09 | 1,462 | 1,462 | 1,434 | 1,447 | -3 | -0.2% | 124,600 |
2023/08/08 | 1,445 | 1,468 | 1,445 | 1,450 | -5 | -0.3% | 115,200 |
2023/08/07 | 1,440 | 1,460 | 1,431 | 1,455 | +14 | +1% | 75,800 |
2023/08/04 | 1,460 | 1,460 | 1,437 | 1,441 | -25 | -1.7% | 141,800 |
2023/08/03 | 1,493 | 1,493 | 1,466 | 1,466 | -37 | -2.5% | 157,600 |
2023/08/02 | 1,495 | 1,516 | 1,495 | 1,503 | -4 | -0.3% | 114,400 |
2023/08/01 | 1,508 | 1,521 | 1,493 | 1,507 | -2 | -0.1% | 211,600 |
2023/07/31 | 1,551 | 1,566 | 1,500 | 1,509 | -76 | -4.8% | 374,600 |
2023/07/28 | 1,564 | 1,585 | 1,562 | 1,585 | +4 | +0.3% | 123,100 |
2023/07/27 | 1,575 | 1,585 | 1,568 | 1,581 | +6 | +0.4% | 61,900 |
2023/07/26 | 1,585 | 1,585 | 1,567 | 1,575 | -8 | -0.5% | 83,200 |
2023/07/25 | 1,590 | 1,590 | 1,577 | 1,583 | -2 | -0.1% | 61,200 |
2023/07/24 | 1,583 | 1,590 | 1,566 | 1,585 | +16 | +1% | 82,800 |
2023/07/21 | 1,554 | 1,574 | 1,554 | 1,569 | +17 | +1.1% | 93,700 |
2023/07/20 | 1,562 | 1,563 | 1,547 | 1,552 | -15 | -1% | 54,200 |
2023/07/19 | 1,560 | 1,567 | 1,557 | 1,567 | +20 | +1.3% | 72,000 |
2023/07/18 | 1,548 | 1,553 | 1,533 | 1,547 | -5 | -0.3% | 55,100 |
2023/07/14 | 1,563 | 1,565 | 1,547 | 1,552 | +5 | +0.3% | 43,900 |
2023/07/13 | 1,534 | 1,548 | 1,523 | 1,547 | +14 | +0.9% | 82,600 |
2023/07/12 | 1,540 | 1,544 | 1,528 | 1,533 | -15 | -1% | 110,300 |
2023/07/11 | 1,562 | 1,562 | 1,542 | 1,548 | +4 | +0.3% | 85,200 |
2023/07/10 | 1,538 | 1,550 | 1,528 | 1,544 | +6 | +0.4% | 119,800 |
2023/07/07 | 1,536 | 1,548 | 1,527 | 1,538 | +2 | +0.1% | 79,500 |
2023/07/06 | 1,553 | 1,555 | 1,527 | 1,536 | -26 | -1.7% | 131,100 |
2023/07/05 | 1,571 | 1,571 | 1,553 | 1,562 | -10 | -0.6% | 98,300 |
2023/07/04 | 1,563 | 1,579 | 1,558 | 1,572 | +9 | +0.6% | 115,400 |
2023/07/03 | 1,550 | 1,571 | 1,550 | 1,563 | +24 | +1.6% | 129,700 |
2023/06/30 | 1,551 | 1,551 | 1,522 | 1,539 | +2 | +0.1% | 119,600 |
401~
450
件表示中 / 6946件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 222,200円 | +0.4% | -8.4% | 2.39% | 28.52倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
あすかHD | 229,600円 | +0.3% | +2.7% | 2.18% | 13.02倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム